Kalbitor

Product manufactured by Dyax Corp.

Application Nr Approved Date Route Status External Links
BLA125277 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Kalbitor ® (Ecallantide) Is Indicated For Treatment Of Acute Attacks Of Hereditary Angioedema (Hae) In Patients 12 Years Of Age And Older. Kalbitor Is A Plasma Kallikrein Inhibitor Indicated For Treatment Of Acute Attacks Of Hereditary Angioedema (Hae) In Patients 12 Years Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ecallantide

Comments